Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Drops MNC Negotiation Plans Without New Drug Price Controls

This article was originally published in PharmAsia News

Executive Summary

India's delay in adopting a new drug price control plan has had a fallout effect on other plans to reduce the cost of imported drugs and medical devices. The government had planned to conduct negotiations with multinational drug makers, but canceled them when several ministries involved could not reach agreement on a new price control plan April 30. That failure was attributed to the Health Ministry, the same ministry that had planned to negotiate with the MNCs. (Click here for more
UsernamePublicRestriction

Register

SC068462

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel